Reduced Graft-Versus-Host Disease-Inducing Capacity of T Cells After Activation, Culturing, and Magnetic Cell Sorting Selection in an Allogeneic Bone Marrow Transplantation Model in Rats
- 20 January 2002
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 13 (2) , 187-198
- https://doi.org/10.1089/10430340252769725
Abstract
Graft-versus-host disease (GvHD), a major complication of allogeneic bone marrow transplantation, has been ascribed to mature T cells in the graft. Because T cells play an important role in engraftment of the bone marrow and decrease the probability of relapse of leukemia, a treatment strategy was developed to preserve the benefits of T cells in the graft and to control the severe complications of GvHD. This can be accomplished by the genetic modification of donor T cells with a suicide gene that allows their selective in vivo elimination and subsequently the abrogation of GvHD. For clinical benefit the alloreactivity of herpes simplex virus thymidine kinase (HSV-TK) gene-transduced T cells should be retained. Therefore, we investigated the influence of gene transduction and the selection procedure on T cells. We demonstrated that activation and culturing of T cells reduce their capacity to induce lethal GvHD in an allogeneic rat bone marrow transplantation model. Furthermore, positive immunomagnetic selection of gene-transduced T cells resulted in loss of the GvHD-inducing capacity of HSV-TK+ T cells directly after MACS (magnetic cell sorting) selection; this loss could be recovered by a 1-day expansion of the selected T cells. No effect on alloreactivity was observed to be caused by the gene transduction procedure. Our study resulted in the development of an optimized culture and gene transduction protocol with preservation of T cell alloreactivity. Treatment of transplanted rats with ganciclovir resulted in a rapid reduction in the number of HSV-TK+ T cells in the peripheral blood and in increased survival of the animals.Keywords
This publication has 33 references indexed in Scilit:
- Retrovirus-Mediated Gene Transfer in Primary T Lymphocytes: Influence of the Transduction/Selection Process and ofex VivoExpansion on the T Cell Receptor β Chain Hypervariable Region RepertoireHuman Gene Therapy, 2000
- Retrovirus-Mediated Gene Transfer into T Cells: 95% Transduction Efficiency without Furtherin VitroSelectionHuman Gene Therapy, 2000
- Production and culture of HSVtk transduced suicidal lymphocytes induces variable changes in the lymphocyte subset compositionBone Marrow Transplantation, 1999
- Herpes Simplex Virus Thymidine Kinase Gene Transfer for Controlled Graft-versus-Host Disease and Graft-versus-Leukemia: Clinical Follow-up and Improved New VectorsHuman Gene Therapy, 1998
- A retroviral vector system ‘STITCH’ in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytesGene Therapy, 1998
- IN VIVO ALLOREACTIVE POTENTIAL OF EX VIVO-EXPANDED PRIMARY T LYMPHOCYTES1Transplantation, 1998
- Adoptive Immunotherapy for Leukemia: Donor Lymphocytes Transduced with the Herpes Simplex Thymidine Kinase Gene for Remission Induction. Human Gene Therapy Research Institute, Des Moines, Iowa, and Northwestern University School of Medicine, Chicago, IllinoisHuman Gene Therapy, 1998
- HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-LeukemiaScience, 1997
- Use of Donor T-Lymphocytes Expressing Herpes-Simplex Thymidine Kinase in Allogeneic Bone Marrow Transplantation: A Phase I–II Study. Laboratorie d'Histocompatibilité et Thérapeutique Immuno-Moléculaire, Besançon, FranceHuman Gene Therapy, 1997
- The Role of Adhesion and Costimulation Molecules in Graft-versus-Host DiseaseActa Haematologica, 1997